Tuberculosis News and Research

Latest Tuberculosis News and Research

China earns a malaria-free certification from WHO

Following a 70-year effort, China has been awarded a malaria-free certification from WHO – a notable feat for a country that reported 30 million cases of the disease annually in the 1940s.

28 Jul 2021

A novel interferon-γ release assay for detection of SARS-CoV-2 specific T-cell response

A new study evaluates a commercially available IFN‐γ release assay (IGRA) to determine T-cell responses targeted against SARS-CoV-2.

26 Jul 2021

Cell-analysis method could pave the way for new vaccine strategies against tuberculosis

A new method that analyzes how individual immune cells react to the bacteria that cause tuberculosis could pave the way for new vaccine strategies against this deadly disease, and provide insights into fighting other infectious diseases around the world.

22 Jul 2021

Owlstone Medical publishes data on the use of face mask filters to capture viral particles for SARS-CoV-2 detection

Owlstone Medical today announced the publication of a peer-reviewed study in Nature Scientific Reports.

From Owlstone Medical Ltd 20 Jul 2021

New consortium launched to advance anti-tuberculosis science

To advance anti-tuberculosis (TB) science and enable the progression of new, safe, and affordable treatment solutions for TB patients worldwide, a new consortium of 30 partners from 13 countries has officially launched.

15 Jul 2021

Researchers examine the effect of silicon intake on lung morphology of rodents

Bone density, skin and hair health, and the mobility of joints depend to a great extent on the microelement of silicon.

15 Jul 2021

Study opens up new opportunities for controlling tuberculosis

Boosting the body's own disease-fighting immune pathway could provide answers in the desperate search for new treatments for tuberculosis.

12 Jul 2021

Repurposed drugs for COVID-19 treatment identified through virtual screening and cell-based assays

A joint research group from KAIST and Institut Pasteur Korea has identified repurposed drugs for COVID-19 treatment through virtual screening and cell-based assays.

8 Jul 2021

Study addresses potential interrelations between AID/APOBECs and the SARS-CoV-2 virus

Together with their multifaceted action mechanisms, activation-induced cytidine deaminase (AID) and so-called APOBEC proteins are important factors in the body's immune response and offer fast and effective protection against a large number of DNA and RNA viruses.

7 Jul 2021

Researchers identify proteins that contribute to the pathogenicity of COVID-19 virus

Researchers at Texas Biomedical Research Institute (Texas Biomed) have narrowed down the proteins enabling SARS-CoV-2 to cause disease.

1 Jul 2021

Researchers determine molecular structure of bacterial protein complex critical for tuberculosis

Tuberculosis is one of the top ten causes of death worldwide, infecting about one-quarter of the world's population. Although it is treatable, the rise of multidrug-resistant tuberculosis poses a major threat to global health security, and has been declared by the World Health Organization as a global health emergency.

25 Jun 2021

Could polio vaccines induce cross-reactive antibodies that target SARS-CoV-2?

A new preprint released on the medRxiv* server explores a link between immunity to SARS-CoV-2, the earlier SARS-CoV, and childhood poliovirus vaccination. Almost 90% of the world’s people have received this vaccine, but antibodies elicited by it reduce over time and are almost absent at the end of adolescence.

24 Jun 2021

Combination of doxycycline and TB drug treatment reduces the size of lung cavities

Globally, an estimated 10 million people develop tuberculosis (TB) each year and the disease remains a leading cause of death from a single infectious agent. Standard short-course anti-TB treatment still requires a regimen of at least six months of antimicrobial drugs, and drug-resistant TB is an increasing public health threat.

21 Jun 2021

New program reveals high burden of undiagnosed or poorly controlled diseases in rural South Africa

A comprehensive health-screening program in rural northern KwaZulu-Natal, South Africa, has found a high burden of undiagnosed or poorly controlled non-communicable diseases, according to a study published in The Lancet Global Health.

21 Jun 2021

WHO estimates suicide as one of the leading causes of death

Suicide remains one of the leading causes of death worldwide, according to WHO's latest estimates, published today in "Suicide worldwide in 2019".

20 Jun 2021

Deep learning could transform the ability to accurately interpret HIV test results

Pioneering technology developed by UCL and Africa Health Research Institute researchers could transform the ability to accurately interpret HIV test results, particularly in low- and middle-income countries.

18 Jun 2021

Texas Biomed scientists receive $1 million NIH funding for Ebola research

Scientists have a general idea of how viruses invade and spread in the body, but the precise mechanisms are actually not well understood, especially when it comes to Ebola virus.

18 Jun 2021

Study validates accuracy of new molecular test for tuberculosis diagnosis

The 'Xpert Ultra' molecular test has a greater capacity than its predecessor ('Xpert MTB/RIF') in detecting tuberculosis cases, either passively (i.e. people who attend the hospital with disease symptoms) or actively (searching for possible cases in the community among contacts of cases).

17 Jun 2021

Novel altruistic stem cell defense mechanism may be targeted to develop new COVID-19 vaccines

The SARS-CoV-2 virus that causes COVID-19 may have the ability to reactivate dormant tuberculosis (TB). In a novel study scientists report in The American Journal of Pathology that infection with a specific coronavirus strain reactivated dormant Mycobacterium tuberculosis (MTB) in mice.

16 Jun 2021

Prior vaccination against diphtheria and tetanus associated with less severe COVID-19

The researchers found that individuals with registered diphtheria or tetanus vaccinations were less likely to develop severe COVID-19 than people who had only received other vaccinations. The results of this study are posted to the medRxiv* preprint server.

16 Jun 2021

Tuberculosis News and Research

Latest Tuberculosis News and Research

China earns a malaria-free certification from WHO

A novel interferon-γ release assay for detection of SARS-CoV-2 specific T-cell response

Cell-analysis method could pave the way for new vaccine strategies against tuberculosis

Owlstone Medical publishes data on the use of face mask filters to capture viral particles for SARS-CoV-2 detection

New consortium launched to advance anti-tuberculosis science

Researchers examine the effect of silicon intake on lung morphology of rodents

Study opens up new opportunities for controlling tuberculosis

Repurposed drugs for COVID-19 treatment identified through virtual screening and cell-based assays

Study addresses potential interrelations between AID/APOBECs and the SARS-CoV-2 virus

Researchers identify proteins that contribute to the pathogenicity of COVID-19 virus

Researchers determine molecular structure of bacterial protein complex critical for tuberculosis

Could polio vaccines induce cross-reactive antibodies that target SARS-CoV-2?

Combination of doxycycline and TB drug treatment reduces the size of lung cavities

New program reveals high burden of undiagnosed or poorly controlled diseases in rural South Africa

WHO estimates suicide as one of the leading causes of death

Deep learning could transform the ability to accurately interpret HIV test results

Texas Biomed scientists receive $1 million NIH funding for Ebola research

Study validates accuracy of new molecular test for tuberculosis diagnosis

Novel altruistic stem cell defense mechanism may be targeted to develop new COVID-19 vaccines

Prior vaccination against diphtheria and tetanus associated with less severe COVID-19

Innovation in neuroscience drug discovery - eBook eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Tuberculosis News and Research

Latest Tuberculosis News and Research

Innovation in neuroscience drug discovery - eBook eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in